<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font6" size="11" family="GillSans,Bold" color="#000000"/>
<text top="41" left="55" width="249" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Current Controlled Trials in Cardiovascular Medicine 2005, 6 :6<i>Current Controlled Trials in Cardiovascular Medicine</i></text>
<text top="41" left="378" width="176" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://cvm.controlled-trials.com/content/6/1/6</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="100" segment_no="17" tag_type="text">Page 7 of 14<b>6</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="101" segment_no="18" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="text">great degree of non-accurate, misleading results generated</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="text">by such assessments in daily clinical practice. Two</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="text">examples bellow highlight the consequences of only min-<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="179" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">imal biased assessments (e.g., ± 5 mmHg).</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="5" tag_type="text">An overestimating systematic error of 5 mmHg would</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="5" tag_type="text">misclassify some 27 million people as being hypertensive</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="5" tag_type="text">rather than having normal-high blood pressure, i.e., pre-</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="5" tag_type="text">hypertension [67]. The individual and societal conse-</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="5" tag_type="text">quences of initiating drug treatment in this segment of the</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="5" tag_type="text">population might be huge and, eventually translate into a</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="5" tag_type="text">real public health burden. Namely, patients with a low<a href="">sion [67]</a>. The individual and societal conse-</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="5" tag_type="text">absolute risk may be exposed to the potential side effects</text>
<text top="239" left="55" width="205" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="5" tag_type="text">of a treatment for little or no therapeutic benefit.</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="7" tag_type="text">Further, a systematic error of underestimating true blood</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="7" tag_type="text">pressure by 5 mmHg would mean that 21 million people</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="7" tag_type="text">would go untreated as their real hypertension would be</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="7" tag_type="text">labelled as normal-high blood pressure [67]. In this sce-</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="7" tag_type="text">nario, patients with high absolute risk who are misclassi-</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="7" tag_type="text">fied as having controlled hypertension will have a higher</text>
<text top="333" left="55" width="180" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="7" tag_type="text">risk of cardiovascular event than necessary.<a href="">[67]</a>. In this sce-</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="9" tag_type="text">Both these scenarios may occur with rather high probabil-</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="9" tag_type="text">ity in clinical practice given the current, widespread model</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="9" tag_type="text">of healthcare based on a dichotomous paradigm of "yes/</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="9" tag_type="text">no" decision making as to establishing an initial diagno-</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="9" tag_type="text">sis, as to the need to investigate or not investigate or, to</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="9" tag_type="text">treat or not to treat, currently arbitrarily fixed for hyper-</text>
<text top="427" left="55" width="110" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="9" tag_type="text">tension at 140/90 mmHg.</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="10" tag_type="text">Amazingly, the scientific community seems to accept the</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="10" tag_type="text">particular outlook reflected by this dichotomous reason-</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="10" tag_type="text">ing despite widespread awareness that the risk associated</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="10" tag_type="text">with increasing blood pressure is graded and continuous.</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="10" tag_type="text">It begins as low as at 115/75 mmHg [1] and increases</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="10" tag_type="text">gradually without, however, a particular threshold being</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="10" tag_type="text">known on the BP curve that might discriminate between</text>
<text top="533" left="55" width="127" height="9" font="font5" id="p1_t39" reading_order_no="36" segment_no="10" tag_type="text">risk/no risk circumstances [68].<a href=""> mmHg [1</a>] and increases</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="12" tag_type="text">The lack of such a threshold combined with the informa-</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="12" tag_type="text">tion derived from a multitude of clinical trials, convinc-</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="12" tag_type="text">ingly demonstrating the benefits of treatment across all<i>risk/no risk </i></text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="12" tag_type="text">levels of blood pressure in Western populations (not only<a href="">tances [68].</a></text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="12" tag_type="text">in hypertension) [69-71], have generated " the lower the</text>
<text top="615" left="55" width="241" height="9" font="font5" id="p1_t45" reading_order_no="42" segment_no="12" tag_type="text">blood pressure , the better " – treatment philosophy, applica-</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="12" tag_type="text">ble to the general population and advocated as such by</text>
<text top="639" left="55" width="143" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="12" tag_type="text">the majority of current guidelines.</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="16" tag_type="text">The &lt;140/90 mmHg cut-off point (respectively &lt;130/80<a href="">[69-71], have </a>generated "</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="16" tag_type="text">mmHg for those with compelling indications) have been<i>the lower the</i></text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="16" tag_type="text">chosen as treatment goal / target for pharmacologically<i>blood pressure</i></text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="16" tag_type="text">treated hypertensives. These targets are supposed to be</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="16" tag_type="text">pursued aggressively with even three or four drugs if<i>the better</i></text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="16" tag_type="text">needed, in order to achieve "optimal" or "normal" BP in</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="3" tag_type="text">young, middle-aged, or diabetic subjects (below 130/80</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="3" tag_type="text">mmHg), and at least "high-normal" BP in elderly patients</text>
<text top="110" left="313" width="130" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="3" tag_type="text">(i.e., &lt;140/90 mmHg) [72,73].</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="4" tag_type="text">Unfortunately, current evidence indicates that most</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="4" tag_type="text">patients fail to achieve systolic blood pressure below 140</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="4" tag_type="text">mmHg [74-76]. According to a survey of hypertension in<i>goal</i></text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="4" tag_type="text">10 countries worldwide, the proportion of patients</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="4" tag_type="text">achieving a blood pressure target below 140/90 mmHg<i>target </i></text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="4" tag_type="text">ranged from a maximum of 27% in the USA to a mini-</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="4" tag_type="text">mum of less than 3% in Zaire [77]. In clinical trials focus-</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="4" tag_type="text">ing hypertension treatment the control rate is around 6%</text>
<text top="228" left="313" width="20" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="4" tag_type="text">[78].</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="6" tag_type="text">Mancia and Grassi [79] pointed out that even in the case</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="6" tag_type="text">of ideal scenario whereby "patient compliance and physi-</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="6" tag_type="text">cian's expertise were ensured, attaining systolic blood<a href="">Hg) [72,73].</a></text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="6" tag_type="text">pressure control would neither frequently nor easily be</text>
<text top="298" left="313" width="45" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="6" tag_type="text">obtained".</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="8" tag_type="text">Additionally, common sense suggests that there may be a<a href="">74-76]. Accord</a>ing to a survey of hypertension in</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="8" tag_type="text">level at which the benefits of treatment are outweighed by</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="8" tag_type="text">its side effects [80]. Likewise, it is obvious that the abso-</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="8" tag_type="text">lute benefits gained differ substantially between elderly</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="8" tag_type="text">and middle aged people and those with or without pre-<a href=""> in Zaire [77]. In clini</a>cal trials focus-</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="8" tag_type="text">existing cardiovascular disease [81,82]. Appropriate</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="8" tag_type="text">assessment of these variables is a matter of judgement of<a href="">[78].</a></text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="8" tag_type="text">the treating physician, based not on occasional blood<a href=""> [79] po</a>inted out that even in the case</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="8" tag_type="text">pressure measurements but rather, on complex clinical</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="8" tag_type="text">decision making employed on a case-to-case basis [83-</text>
<text top="439" left="313" width="17" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="8" tag_type="text">88].</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="11" tag_type="text">The aforementioned major problems with accurately</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="11" tag_type="text">measuring blood pressure in day-to-day clinical practice</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="11" tag_type="text">for the purpose of diagnosis and treatment of hyperten-</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="11" tag_type="text">sion, highlight the magnitude of the uncertainty range<a href="">s [80]</a>. Likewise, it is obvious that the abso-</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="11" tag_type="text">around the current blood pressure cut-off point (140/90</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="11" tag_type="text">mmHg), consisting of huge number of people being mis-</text>
<text top="533" left="313" width="205" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="11" tag_type="text">diagnosed of having or not having hypertension.<a href="">vascular disease [81,82]. </a>Appropriate</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="13" tag_type="text">Failure in both directions are regrettable but, in the con-</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="13" tag_type="text">text of currently increasing aggressive approach to hyper-</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="13" tag_type="text">tension mandated by most guidelines, overdiagnosis</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="13" tag_type="text">exposes people unnecessarily to considerable risk for<a href="">e basis [83-</a></text>
<text top="604" left="313" width="126" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="13" tag_type="text">adverse drug reactions (ADR).<a href="">88].</a></text>
<text top="627" left="313" width="218" height="10" font="font6" id="p1_t94" reading_order_no="91" segment_no="14" tag_type="title">Poor treatment compliance rates – often a</text>
<text top="639" left="313" width="136" height="10" font="font6" id="p1_t95" reading_order_no="92" segment_no="14" tag_type="title">reflection of overdiagnosis?</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="15" tag_type="text">Patients' low compliance rate with the prescribed medica-</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="15" tag_type="text">tion is a widely acknowledged problem in hypertension</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="15" tag_type="text">treatment. Up to 50% of the patients quit the treatment</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="15" tag_type="text">they were given within the first year [89-92]. Adverse</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="15" tag_type="text">events with antihypertensive treatment are to a large</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="15" tag_type="text">extent dose related. More than 75% of these ADRs occur</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="15" tag_type="text">as such, at initiation of antihypertensive treatment</text>
</page>
</pdf2xml>
